 was no difference in the
composite primary end point of death, stroke and MI between the transfemoral CAS group (3.8% 6 0.59% vs CEA
3.4% 6 0.98% (2.27% conﬁdence interval [CI], P ¼ .01 noninferior). Stroke and death risk was 2.9% for transfemoral CAS
and 1.7% for C